Cigna
CI Β· Health Care Services
$306.95
2.8%Cencora
COR Β· Health Care Distributors
$331.00
2.2%The short version
- Cencora is the larger business, with $321.3B of revenue in fiscal 2025 against $274.9B for Cigna.
- Cigna grew revenue faster (11.2%, against 9.3%).
- Cigna kept more of each dollar of sales as operating profit (3.4% operating margin, against 0.8% operating margin).
- Investors pay more for each dollar of Cencoraβs earnings: a P/E of 24.6x against 12.7x for Cigna.
| Latest fiscal year | CI Β· FY25 | COR Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $81.0B | $64.2B |
| Revenue | $274.9B | $321.3B |
| Free cash flow | β | $3.2B |
| Net income | $6.0B | $1.6B |
| Growth | ||
| Revenue growth | 11.2% | 9.3% |
| 5-year growth | 11.4% | 11.1% |
| Share count change | β5.2% | β2.5% |
| Profitability | ||
| Gross margin | β | 3.6% |
| Operating margin | 3.4% | 0.8% |
| Net margin | 2.2% | 0.5% |
| FCF margin | β | 1.0% |
| Return on capital | 11.7% | β |
| Return on equity | 14.4% | β |
| Balance sheet | ||
| Net debt | $22.1B | $3.3B |
| Net debt / EBITDA | 1.9x | 0.9x |
| Dividends and buybacks | $5.2B | $873M |
| Valuation & quality | ||
| P/E | 12.7x | 24.6x |
| Piotroski F-score | 7 | 7 |
FY16
CI $39.8B
COR $146.8B
FY17
CI $41.8B
COR $153.1B
FY18
CI $48.7B
COR $167.9B
FY19
CI $153.6B
COR $179.6B
FY20
CI $160.4B
COR $189.9B
FY21
CI $174.1B
COR $214.0B
FY22
CI $180.5B
COR $238.6B
FY23
CI $195.3B
COR $262.2B
FY24
CI $247.1B
COR $294.0B
FY25
CI $274.9B
COR $321.3B
CI
COR
FY16
CI 7.8%
COR 1.0%
FY17
CI 9.4%
COR 0.7%
FY18
CI 8.6%
COR 0.9%
FY19
CI 5.3%
COR 0.6%
FY20
CI 5.1%
COR β2.7%
FY21
CI 4.6%
COR 1.1%
FY22
CI 4.7%
COR 1.0%
FY23
CI 4.4%
COR 0.9%
FY24
CI 3.8%
COR 0.7%
FY25
CI 3.4%
COR 0.8%
CI
COR
FY16
CI $3.6B
COR $2.7B
FY17
CI $3.6B
COR $1.0B
FY18
CI $3.2B
COR $1.1B
FY19
CI $8.4B
COR $2.0B
FY20
CI β
COR $1.8B
FY21
CI β
COR $2.2B
FY22
CI β
COR $2.2B
FY23
CI β
COR $3.5B
FY24
CI β
COR $3.0B
FY25
CI β
COR $3.2B
CI
COR
FY16
CI β
COR β
FY17
CI β
COR β
FY18
CI 6.8%
COR 36.4%
FY19
CI 8.5%
COR 22.7%
FY20
CI 9.0%
COR β
FY21
CI 8.8%
COR β
FY22
CI 9.7%
COR β
FY23
CI 12.5%
COR β
FY24
CI 10.4%
COR β
FY25
CI 11.7%
COR β
CI
COR
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.